EPA v. General Electric Healthcare
Case summary
In letters written to EPA , a representative of GEHC admitted violations of section 5 of TSCA when the company failed to submit a premanufacture notification (PMN) to the EPA Administrator, as required by 40 C.F.R. Part 720, regarding the Companys intention to manufacture two new chemical substances.
Defendants (1)
- GE Medical Systems - Electric AvenueNamed in settlement
Facilities (2)
GE MEDICAL SYSTEMS
4855 WEST ELECTIC AVENUE, WEST MILWAUKEE, WI, 53219
Registry ID: 110000418931
GENERAL ELECTRIC HEALTHCARE (GEHC)
101 CARNEGIE CENTER, PRINCETON, NJ, 08540
Registry ID: 110039165195
Statutes cited
- TSCA 5A/5B — Failure To Comply With Significant New Use Rules and Pre-manufacture Notice
Enforcement conclusions (1)
General Electric Healthcareentered 2009-05-12
Primary law: TSCA
Timeline (2 milestones)
- 2009-05-12Final Order Issued
- 2009-05-20Enforcement Action Data Entered
Case metadata
- EPA activity ID
- 1400045552
- Case number
- HQ-2009-5016
- Lead agency
- EPA
- EPA region
- HQ
- Voluntary self-disclosure
- Yes
- Primary statute
- Failure To Comply With Significant New Use Rules and Pre-manufacture Notice
Sourced verbatim from EPA ECHO Enforcement Case Report for case HQ-2009-5016 . Bulk data: ICIS-FEC download summary.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.